Evidence map›Paper›PMID 33499379›Full record

ReviewMicroorganisms2021

A Comprehensive Review of Detection Methods for SARS-CoV-2.

Aziz Eftekhari, Mahdieh Alipour, Leila Chodari, Solmaz Maleki Dizaj, Mohammadreza Ardalan, Mohammad Samiei, Simin Sharifi, Sepideh Zununi Vahed, Irada Huseynova, Rovshan Khalilov and 2 more

Abstract readReview
In one paragraph

Review in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Nanoparticles as an effective drug delivery system in COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Simultaneous and sensitive detection ofFrontiers in bioengineering and biotechnology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aziz EftekhariPharmacology and Toxicology Department, Maragheh University of Medical Sciences, Maragheh 5515878151, Iran.
Mahdieh AlipourDental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.ORCID 0000-0002-9717-8213
Leila ChodariPhysiology Department, Faculty of Medicine, Urmia University of Medical Sciences, Urmia 571478334, Iran.
Solmaz Maleki DizajDental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.
Mohammadreza ArdalanKidney Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.
Mohammad SamieiFaculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.
Simin SharifiDental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.
Sepideh Zununi VahedKidney Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.ORCID 0000-0003-0179-4562
Irada HuseynovaInstitute of Molecular Biology & Biotechnologies, Azerbaijan National Academy of Sciences, 11 Izzat Nabiyev, Baku AZ 1073, Azerbaijan.
Rovshan KhalilovDepartment of Biophysics and Biochemistry, Baku State University, Baku AZ 1148, Azerbaijan.
Elham AhmadianKidney Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz 5166615731, Iran.ORCID 0000-0002-7230-0489
Magali CucchiariniCenter of Experimental Orthopaedics, Saarland University Medical Center, D-66421 Homburg/Saar, Germany.ORCID 0000-0003-0323-8922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the outbreak of the coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, in China and its subsequent spread across the world has caused numerous infections and deaths and disrupted normal social activity. Presently, various techniques are used for the diagnosis of SARS-CoV-2 infection, with various advantages and weaknesses to each. In this paper, we summarize promising methods, such as reverse transcription-polymerase chain reaction (RT-PCR), serological testing, point-of-care testing, smartphone surveillance of infectious diseases, nanotechnology-based approaches, biosensors, amplicon-based metagenomic sequencing, smartphone, and wastewater-based epidemiology (WBE) that can also be utilized for the detection of SARS-CoV-2. In addition, we discuss principles, advantages, and disadvantages of these detection methods, and highlight the potential methods for the development of additional techniques and products for early and fast detection of SARS-CoV-2.

Indexed as

coronavirusCOVID-19detectionepidemicnanotechnology

Identifiers

PMID33499379
PMCPMC7911200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.